Dr. Gelmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
177 Fort Washington Ave
# 6N435
New York, NY 10032Phone+1 212-305-8602
Education & Training
University of ChicagoResidency, Internal Medicine, 1976 - 1978- Stanford University School of MedicineClass of 1976
Certifications & Licensure
- CA State Medical License 1979 - Present
AZ State Medical License 2018 - 2026
DC State Medical License 1988 - 2026
MD State Medical License 1978 - 2026
NY State Medical License 2007 - 2026
IL State Medical License 1977 - 1987
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2009-2014
- America's Top Doctors Castle Connolly, 2006-2014
- New York Magazine: Top Doctors Castle Connolly, 2010-2013
- Join now to see all
Clinical Trials
- Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 2000 May 01
- S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Publications & Presentations
PubMed
- The expanding role of hormones in cancer.Edward P Gelmann
Endocrine Oncology. 2021-01-01 - 6 citationsTissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression.Ximena Leighton, Alakesh Bera, Ofer Eidelman, Lukas Bubendorf, Tobias Zellweger
Plos One. 2018-10-15 - 18 citationsDevelopment, Evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate.Caroline Andrews, Brian Fortier, Amy Hayward, Ruth Lederman, Lindsay Petersen
Journal of Global Oncology. 2018-09-27
Press Mentions
Targeting the Engine Room of the Cancer CellJune 19th, 2018
Targeting the Engine Room of the Cancer CellJune 18th, 2018
Grant Support
- Protocol Specific Research ResourceNational Cancer Institute2008–2011
- Crmo- Clinical Research Management OfficeNational Cancer Institute2008–2011
- Genetic Polymorphism In Prostate CancerNational Institute Of Environmental Health Sciences2007
- Cancer And Leukemia Group BNational Cancer Institute2003–2006
- Genetic Polymorphism In Prostate CancerNational Institute Of Environmental Health Sciences1999–2006
- Beta Catenin In Prostate CancerNational Cancer Institute2002–2005
- Prostate, Lung, Colorectal &Ovarian Cancer Screening Tria-261925522National Cancer Institute2003
- Cancer And Acute Leukemia Group B (CALGB) Inst GrantNational Cancer Institute2001–2002
- Beta Catenin In Prostate CancerNational Cancer Institute2000–2001
- Apoptosis In Prostate CancerNational Cancer Institute1999–2001
- Prostate, Lung, Colorectal &Ovarian CancerDivision Of Cancer Prevention And Control1994–2000
- Nkx31 In Prostate CancerNational Cancer Institute1998–1999
- Markers For Malignant Progression In Prostate CancerNational Cancer Institute1992–1996
- Specialized PGM Of Research Excellence/Prostate CancerNational Cancer Institute1992–1994
- Molecular Mechanisms For Prostate Cancer Cell GrowthNational Cancer Institute1990–1992
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
